| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Access to Disease-Modifying Alzheimer’s Therapies: Addressing Possible Challenges Using Innovative Payment Models
|
Hlávka, Jakub P.
|
|
|
|
11 |
p. 1828-1836
|
artikel
|
| 2 |
A Comparison of Generic and Condition-Specific Preference-Based Measures Using Data From Nivolumab Trials: EQ-5D-3L, Mapping to the EQ-5D-5L, and European Organisation for Research and Treatment of Cancer Quality of Life Utility Measure-Core 10 Dimensions
|
Shaw, James W.
|
|
|
|
11 |
p. 1651-1659
|
artikel
|
| 3 |
A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons
|
Cassidy, Owen
|
|
|
|
11 |
p. 1665-1674
|
artikel
|
| 4 |
A Comprehensive Comparison of Additional Benefit Assessment Methods Applied by Institute for Quality and Efficiency in Health Care and European Society for Medical Oncology for Time-to-Event Endpoints After Significant Phase III Trials—A Simulation Study
|
Büsch, Christopher A.
|
|
|
|
11 |
p. 1853-1862
|
artikel
|
| 5 |
A Pragmatic Guide to Assessing Real Option Value for Medical Technologies
|
Li, Meng
|
|
|
|
11 |
p. 1878-1884
|
artikel
|
| 6 |
A Simulation-Based Cost-Effectiveness Analysis of Severe Acute Respiratory Syndrome Coronavirus 2 Infection Prevention Strategies for Visitors of Healthcare Institutions
|
Bartenschlager, Christina C.
|
|
|
|
11 |
p. 1846-1852
|
artikel
|
| 7 |
Assessing Lung Cancer Screening Programs under Uncertainty in a Heterogeneous Population
|
Broekhuizen, Henk
|
|
2018
|
|
11 |
p. 1269-1277
|
artikel
|
| 8 |
Assessment of Studies Evaluating Incremental Costs, Effectiveness, or Cost-Effectiveness of Systemic Therapies in Breast Cancer Based on Claims Data: A Systematic Review
|
Luyendijk, Marianne
|
|
|
|
11 |
p. 1497-1508
|
artikel
|
| 9 |
Association Between Receipt of Definitive Treatment for Localized Prostate Cancer and Adverse Health Outcomes: A Claims-Based Approach
|
Mitchell, Jean M.
|
|
|
|
11 |
p. 1863-1870
|
artikel
|
| 10 |
A Systematic Review of Patient-Reported Satisfaction with Oral Medication Therapy in Patients with Type 2 Diabetes
|
Wang, Yu
|
|
2018
|
|
11 |
p. 1346-1353
|
artikel
|
| 11 |
Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group
|
|
|
|
|
11 |
p. 1522
|
artikel
|
| 12 |
Body of Evidence for Onasemnogene Abeparvovec in Spinal Muscular Atrophy Supports Long-Term Duration of Effect Without Relapse
|
Dean, Rebecca
|
|
|
|
11 |
p. 1922-1923
|
artikel
|
| 13 |
Budget Impact of Next-Generation Sequencing for Molecular Assessment of Advanced Non–Small Cell Lung Cancer
|
Yu, Tiffany M.
|
|
2018
|
|
11 |
p. 1278-1285
|
artikel
|
| 14 |
Calculating the Expected Value of Sample Information Using Efficient Nested Monte Carlo: A Tutorial
|
Heath, Anna
|
|
2018
|
|
11 |
p. 1299-1304
|
artikel
|
| 15 |
Cancer Drug Prices in the United States: Efficacy, Innovation, Clinical Trial Evidence, and Epidemiology
|
Michaeli, Daniel Tobias
|
|
|
|
11 |
p. 1590-1600
|
artikel
|
| 16 |
Can Independently Elicited Adult- and Child-Perspective Health-State Utilities Explain Priority Setting?
|
Attema, Arthur E.
|
|
|
|
11 |
p. 1645-1654
|
artikel
|
| 17 |
Cannabis and Health Research: Rapid Progress Requires Innovative Research Designs
|
Hutchison, Kent E.
|
|
2019
|
|
11 |
p. 1289-1294
|
artikel
|
| 18 |
Challenging Assumptions of Outcomes and Costs Comparing Peritoneal and Hemodialysis
|
Lin, Eugene
|
|
|
|
11 |
p. 1592-1602
|
artikel
|
| 19 |
Copyright/Subscription
|
|
|
|
|
11 |
p. iv
|
artikel
|
| 20 |
Copyright/Subscription
|
|
|
2018
|
|
11 |
p. ii
|
artikel
|
| 21 |
Copyright/Subscription
|
|
|
2019
|
|
11 |
p. iv
|
artikel
|
| 22 |
Copyright/Subscription
|
|
|
|
|
11 |
p. v
|
artikel
|
| 23 |
Copyright/Subscription
|
|
|
|
|
11 |
p. iv
|
artikel
|
| 24 |
Copyright/Subscription
|
|
|
|
|
11 |
p. iii
|
artikel
|
| 25 |
Coronavirus Disease 2019: Considerations for Health Technology Assessment From the National Centre for Pharmacoeconomics Review Group
|
Leahy, Joy
|
|
|
|
11 |
p. 1423-1426
|
artikel
|
| 26 |
Cost-Effectiveness of Antiviral Treatments for Pandemics and Outbreaks of Respiratory Illnesses, Including COVID-19: A Systematic Review of Published Economic Evaluations
|
Dawoud, Dalia M.
|
|
|
|
11 |
p. 1409-1422
|
artikel
|
| 27 |
Cost-Effectiveness of Care Coordination for Children With Chronic Noncomplex Medical Conditions: Results From a Multicenter Randomized Clinical Trial
|
Carter, Hannah E.
|
|
|
|
11 |
p. 1837-1845
|
artikel
|
| 28 |
Cost-Effectiveness of COVID-19 Policy Measures: A Systematic Review
|
Vandepitte, Sophie
|
|
|
|
11 |
p. 1551-1569
|
artikel
|
| 29 |
Cost-Effectiveness of Immediate Magnetic Resonance Imaging In the Management of Patients With Suspected Scaphoid Fracture: Results From a Randomized Clinical Trial
|
Rua, Tiago
|
|
|
|
11 |
p. 1444-1452
|
artikel
|
| 30 |
Cost-Effectiveness of Magnetic Resonance Imaging-Guided Thrombolysis for Patients With Stroke With Unknown Time of Onset
|
Muntendorf, Louisa-Kristin
|
|
|
|
11 |
p. 1620-1627
|
artikel
|
| 31 |
Cost-Effectiveness of One-Time Birth Cohort Screening for Hepatitis C as Part of the National Health Service Health Check Program in England
|
Williams, Jack
|
|
2019
|
|
11 |
p. 1248-1256
|
artikel
|
| 32 |
Costing of Essential Health Service Packages: A Systematic Review of Methods From Developing Economies
|
Jeet, Gursimer
|
|
|
|
11 |
p. 1700-1713
|
artikel
|
| 33 |
Costing the COVID-19 Pandemic: An Exploratory Economic Evaluation of Hypothetical Suppression Policy in the United Kingdom
|
Zala, Darshan
|
|
|
|
11 |
p. 1432-1437
|
artikel
|
| 34 |
Do Centers for Medicare and Medicaid Services Quality Measures Reflect Cost-Effectiveness Evidence?
|
van Dover, Timothy J.
|
|
|
|
11 |
p. 1586-1591
|
artikel
|
| 35 |
Editorial Board
|
|
|
|
|
11 |
p. v
|
artikel
|
| 36 |
Editorial Board
|
|
|
2018
|
|
11 |
p. IFC
|
artikel
|
| 37 |
Editorial Board
|
|
|
2019
|
|
11 |
p. v
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
11 |
p. vi
|
artikel
|
| 39 |
Editorial Board
|
|
|
|
|
11 |
p. v
|
artikel
|
| 40 |
Editorial Board
|
|
|
|
|
11 |
p. iv
|
artikel
|
| 41 |
Effect of Reflection and Deliberation on Health State Values: A Mixed-Methods Study
|
Karimi, Milad
|
|
2019
|
|
11 |
p. 1311-1317
|
artikel
|
| 42 |
Estimated Savings From Using Added Therapeutic Benefit and Therapeutic Reference Pricing in United States Medicare Drug Price Negotiations
|
DiStefano, Michael J.
|
|
|
|
11 |
p. 1618-1624
|
artikel
|
| 43 |
Evidence of Stability in Patient-Reported Global Health During the COVID-19 Pandemic
|
Lapin, Brittany R.
|
|
|
|
11 |
p. 1578-1585
|
artikel
|
| 44 |
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review: An ISPOR Special Interest Group Report
|
Cangelosi, Michael
|
|
|
|
11 |
p. 1581-1589
|
artikel
|
| 45 |
Finite Mixture Models, a Flexible Alternative to Standard Modeling Techniques for Extrapolated Mean Survival Times Needed for Cost-Effectiveness Analyses
|
Cislo, Paul R.
|
|
|
|
11 |
p. 1643-1650
|
artikel
|
| 46 |
General Population Norms for the Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue Scale
|
Montan, Inka
|
|
2018
|
|
11 |
p. 1313-1321
|
artikel
|
| 47 |
Head-to-Head Comparison of the Psychometric Properties of 3 Carer-Related Preference-Based Instruments
|
McCaffrey, Nikki
|
|
|
|
11 |
p. 1477-1488
|
artikel
|
| 48 |
Health State Values Derived from People with Multiple Sclerosis for a Condition-Specific Preference-Based Measure: Multiple Sclerosis Impact Scale–Eight Dimensions–Patient Version (MSIS-8D-P)
|
Goodwin, Elizabeth
|
|
2018
|
|
11 |
p. 1338-1345
|
artikel
|
| 49 |
Health Utilities and Costs for Motor Neurone Disease
|
Moore, Alan
|
|
2019
|
|
11 |
p. 1257-1265
|
artikel
|
| 50 |
Hemophilia Gene Therapy Value Assessment: Methodological Challenges and Recommendations
|
Garrison, Louis P.
|
|
|
|
11 |
p. 1628-1633
|
artikel
|
| 51 |
Impact of Persisting Amblyopia on Socioeconomic, Health, and Well-Being Outcomes in Adult Life: Findings From the UK Biobank
|
Bountziouka, Vasiliki
|
|
|
|
11 |
p. 1603-1611
|
artikel
|
| 52 |
Impact of Star Rating Medication Adherence Measures on Adherence for Targeted and Nontargeted Medications
|
Parekh, Natasha
|
|
2019
|
|
11 |
p. 1266-1274
|
artikel
|
| 53 |
Influence of Self-Reported Health Impairments on German EQ-5D-5L Values
|
Elkenkamp, Svenja
|
|
|
|
11 |
p. 1636-1644
|
artikel
|
| 54 |
Informing Balanced Investment in Services and Health Systems: A Case Study of Priority Setting for Tuberculosis Interventions in South Africa
|
Bozzani, Fiammetta M.
|
|
|
|
11 |
p. 1462-1469
|
artikel
|
| 55 |
Mapping ALSFRS-R and ALSUI to EQ-5D in Patients with Motor Neuron Disease
|
Moore, Alan
|
|
2018
|
|
11 |
p. 1322-1329
|
artikel
|
| 56 |
Mapping the Patient-Oriented Prostate Utility Scale From the Expanded Prostate Cancer Index Composite and the Short-Form Health Surveys
|
Zamora, Víctor
|
|
|
|
11 |
p. 1676-1685
|
artikel
|
| 57 |
Measurement Instruments of Productivity Loss of Paid and Unpaid Work: A Systematic Review and Assessment of Suitability for Health Economic Evaluations From a Societal Perspective
|
Hubens, Kimberley
|
|
|
|
11 |
p. 1686-1699
|
artikel
|
| 58 |
Measurement Properties of the EQ-5D-Y: A Systematic Review
|
Golicki, Dominik
|
|
|
|
11 |
p. 1910-1921
|
artikel
|
| 59 |
Measuring “Fearonomic Effects” in Valuing Therapies: An Application to COVID-19 in China
|
Ma, Siyu
|
|
|
|
11 |
p. 1405-1408
|
artikel
|
| 60 |
Modeling the Cost-Utility of Treatment Sequences for Multiple Sclerosis
|
Huygens, Simone
|
|
|
|
11 |
p. 1612-1619
|
artikel
|
| 61 |
Modeling the Recovery of Elective Waiting Lists Following COVID-19: Scenario Projections for England
|
Howlett, Nicholas C.
|
|
|
|
11 |
p. 1805-1813
|
artikel
|
| 62 |
Modifying the Criteria for Granting Orphan Drug Market Exclusivity
|
Socal, Mariana P.
|
|
|
|
11 |
p. 1470-1476
|
artikel
|
| 63 |
Multicriteria Decision Analysis to Support Health Technology Assessment Agencies: Benefits, Limitations, and the Way Forward
|
Baltussen, Rob
|
|
2019
|
|
11 |
p. 1283-1288
|
artikel
|
| 64 |
No Time to Waste: An Appraisal of Value at the End of Life
|
Quinn, Kieran L.
|
|
|
|
11 |
p. 1902-1909
|
artikel
|
| 65 |
On the (Near) Equivalence of Welfarist and Extra-Welfarist Methods to Value Healthcare With Implications for Assessing Equity
|
Phelps, Charles E.
|
|
|
|
11 |
p. 1601-1607
|
artikel
|
| 66 |
Optimization Models for HIV/AIDS Resource Allocation: A Systematic Review
|
Avanceña, Anton L.V.
|
|
|
|
11 |
p. 1509-1521
|
artikel
|
| 67 |
Patient Self-Reported Health, Clinical Quality, and Patient Satisfaction in English Primary Care: Practice-Level Longitudinal Observational Study
|
Feng, Yan
|
|
|
|
11 |
p. 1660-1666
|
artikel
|
| 68 |
Performance of the EQ-5D-5L Plus Respiratory Bolt-On in the Birmingham Chronic Obstructive Pulmonary Disease Cohort Study
|
Hoogendoorn, Martine
|
|
|
|
11 |
p. 1667-1675
|
artikel
|
| 69 |
Pneumococcal Disease: A Systematic Review of Health Utilities, Resource Use, Costs, and Economic Evaluations of Interventions
|
Shiri, Tinevimbo
|
|
2019
|
|
11 |
p. 1329-1344
|
artikel
|
| 70 |
Practical Guidance for Including Future Costs in Economic Evaluations in The Netherlands: Introducing and Applying PAID 3.0
|
Kellerborg, Klas
|
|
|
|
11 |
p. 1453-1461
|
artikel
|
| 71 |
Predicting Hospital Resource Use During COVID-19 Surges: A Simple but Flexible Discretely Integrated Condition Event Simulation of Individual Patient-Hospital Trajectories
|
Caro, J. Jaime
|
|
|
|
11 |
p. 1570-1577
|
artikel
|
| 72 |
Predictors of Drug Shortages and Association with Generic Drug Prices: A Retrospective Cohort Study
|
Dave, Chintan V.
|
|
2018
|
|
11 |
p. 1286-1290
|
artikel
|
| 73 |
Projected Cost-Effectiveness for 2 Gene-Drug Pairs Using a Multigene Panel for Patients Undergoing Percutaneous Coronary Intervention
|
Hart, M. Ragan
|
|
2019
|
|
11 |
p. 1231-1239
|
artikel
|
| 74 |
Psychometric Evaluation of the Patient’s Knee Implant Performance Questionnaire
|
Coles, Theresa
|
|
2018
|
|
11 |
p. 1305-1312
|
artikel
|
| 75 |
Real Option Value: Should We Opt In or Out?
|
Towse, Adrian
|
|
|
|
11 |
p. 1818-1820
|
artikel
|
| 76 |
Stroke Warning Information and Faster Treatment (SWIFT): Cost-Effectiveness of a Stroke Preparedness Intervention
|
Stevens, Elizabeth R.
|
|
2019
|
|
11 |
p. 1240-1247
|
artikel
|
| 77 |
Table of Contents
|
|
|
|
|
11 |
p. i-iii
|
artikel
|
| 78 |
Table of Contents
|
|
|
2018
|
|
11 |
p. i
|
artikel
|
| 79 |
Table of Contents
|
|
|
2019
|
|
11 |
p. i-iii
|
artikel
|
| 80 |
Table of Contents
|
|
|
|
|
11 |
p. i-iv
|
artikel
|
| 81 |
Table of Contents
|
|
|
|
|
11 |
p. i-iii
|
artikel
|
| 82 |
Table of Contents
|
|
|
|
|
11 |
p. i-ii
|
artikel
|
| 83 |
Testing the “Nonstopping” Time Trade-Off: Is It Better Than the Composite Time Trade-Off?
|
Luo, Nan
|
|
|
|
11 |
p. 1489-1496
|
artikel
|
| 84 |
The Economic and Public Health Imperatives Around Making Potential Coronavirus Disease–2019 Treatments Available and Affordable
|
Forsythe, Steven
|
|
|
|
11 |
p. 1427-1431
|
artikel
|
| 85 |
The Extrapolation Performance of Survival Models for Data With a Cure Fraction: A Simulation Study
|
Kearns, Benjamin
|
|
|
|
11 |
p. 1634-1642
|
artikel
|
| 86 |
The Feasibility and Validity of Preference-Based Quality of Life Measures With Informal Carers: A Think-Aloud Study
|
McLoughlin, Carol
|
|
|
|
11 |
p. 1655-1664
|
artikel
|
| 87 |
The Garbage Class Mixed Logit Model: Accounting for Low-Quality Response Patterns in Discrete Choice Experiments
|
Jonker, Marcel F.
|
|
|
|
11 |
p. 1871-1877
|
artikel
|
| 88 |
The Hip Disability and Osteoarthritis Outcome Score-Physical Function Shortform Does Not Adequately Represent Physical Functioning in Patients Undergoing Total Hip Arthroplasty
|
Braaksma, Christel
|
|
|
|
11 |
p. 1894-1901
|
artikel
|
| 89 |
The Joint Committee on Vaccination and Immunisation’s Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?
|
O’Mahony, James F.
|
|
2019
|
|
11 |
p. 1227-1230
|
artikel
|
| 90 |
The National Hospital Care Survey Is a Unique Source of Data on Rare Diseases
|
Strashny, Alex
|
|
|
|
11 |
p. 1814-1817
|
artikel
|
| 91 |
The Role of Health Economics and Outcomes Research in Addressing Coronavirus Disease 2019 (COVID-19)
|
Mullins, C. Daniel
|
|
|
|
11 |
p. 1403-1404
|
artikel
|
| 92 |
Time Trade-Off Value Set for EQ-5D-3L Based on a Nationally Representative Chinese Population Survey
|
Zhuo, Lang
|
|
2018
|
|
11 |
p. 1330-1337
|
artikel
|
| 93 |
Toward a Smaller Design for EQ-5D-5L Valuation Studies
|
Yang, Zhihao
|
|
2019
|
|
11 |
p. 1295-1302
|
artikel
|
| 94 |
Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions
|
Weymann, Deirdre
|
|
|
|
11 |
p. 1608-1617
|
artikel
|
| 95 |
UK Valuation of EQ-5D-5L, a Generic Measure of Health-Related Quality of Life: A Study Protocol
|
Rowen, Donna
|
|
|
|
11 |
p. 1625-1635
|
artikel
|
| 96 |
Unmet Medical Need: An Introduction to Definitions and Stakeholder Perceptions
|
Vreman, Rick A.
|
|
2019
|
|
11 |
p. 1275-1282
|
artikel
|
| 97 |
Using Patient-Reported Outcome Measures to Evaluate Care for Patients With Inflammatory Chronic Rheumatic Disease
|
Rodrigues, Daniela
|
|
|
|
11 |
p. 1885-1893
|
artikel
|
| 98 |
Validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Summary Score in Patients With Hematologic Malignancies
|
Efficace, Fabio
|
|
2019
|
|
11 |
p. 1303-1310
|
artikel
|
| 99 |
Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective
|
Kreimeier, Simone
|
|
2018
|
|
11 |
p. 1291-1298
|
artikel
|
| 100 |
What Is Next for Patient Preferences in Health Technology Assessment? A Systematic Review of the Challenges
|
Huls, Samare P.I.
|
|
2019
|
|
11 |
p. 1318-1328
|
artikel
|
| 101 |
Why We Need a New Outcomes-Based Value Attribution Framework for Combination Regimens in Oncology
|
Towse, Adrian
|
|
|
|
11 |
p. 1821-1827
|
artikel
|
| 102 |
Will Americans Get Vaccinated? Predicting COVID-19 Vaccine Uptake Rates Under Contingent Scenarios
|
Vásquez, William F.
|
|
|
|
11 |
p. 1543-1550
|
artikel
|
| 103 |
Willingness to Accept Trade-Offs Among COVID-19 Cases, Social-Distancing Restrictions, and Economic Impact: A Nationwide US Study
|
Reed, Shelby
|
|
|
|
11 |
p. 1438-1443
|
artikel
|
Tijdschrift beschrijving